FTC Gives Green Light To ANI-Novitium Acquisition Conditions
Follows Public Comment Period; ANI Announced Completion In November
ANI is now firmly in the clear for its $210m acquisition of Novitium, following FTC approval of an order requiring divestiture of rights and assets to two generic products. The US-based firm is on an upward trajectory following its recent approval for Cortrophin Gel.
